Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Molecular Skin Therapeutics describes dual kallikrein 5/7 inhibitors

April 30, 2021

Cara reports phase II topline data on oral Korsuva for pruritus in atopic dermatitis

April 29, 2021

Amgen initiates phase IIb trial of tezepelumab for chronic spontaneous urticaria

April 29, 2021

Hisamitsu reports phase III results with HP-5070 in primary palmar hyperhidrosis

April 28, 2021

China's NMPA approves IND for IL-23p19-targeting antibody NBL-012

April 28, 2021

Second pivotal study of IDP-126 achieves all coprimary endpoints with statistical significance

April 23, 2021

Baricitinib improves hair regrowth in patients with alopecia areata in second BRAVE-AA trial

April 21, 2021

First patients treated in phase I/II trial of pyrilutamide for acne in China

April 19, 2021

Genentech and Roche discover new KLK7-targeting antibodies

April 12, 2021

Allosteric MALT1 inhibitors from Toray Industries for the treatment of psoriasis

April 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...